Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations

Journal of Autoimmunity

Volumn 34, Issue 2, 2010, Pages 155-162

  Gourh, Pravitt ^a   Agarwal, Sandeep K ^a   Martin, Ezequiel ^b   Divecha, Dipal ^a   Rueda, Blanca ^b   Bunting, Haley ^a   Assassi, Shervin ^a   Paz, Gene ^a   Shete, Sanjay ^c   McNearney, Terry ^d   Draeger, Hilda ^e   Reveille, John D ^a   Radstake, T R D J ^f   Simeon, Carmen P ^g   Rodriguez, Luis ^h   Vicente, Esther ⁱ   Gonzalez Gay, Miguel A ^j   Mayes, Maureen D ^a   Tan, Filemon K ^a   Martin, Javier ^b   Arnett, Frank C ^a   more..

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^j HOSPITAL XERAL CALDE   (Spain)

more..

Author keywords

Anti centromere; Anti Topoisomerase I; Autoantibody; BLK; C8orf13; Genetics; Polymorphism SNP; rs13277113; rs2736340; Scleroderma; Systemic sclerosis SSc

Indexed keywords

B LYMPHOCYTE RECEPTOR; B LYMPHOID TYROSINE KINASE; CENTROMERE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C8ORF13; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CHROMOSOME 8P; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPE; FEMALE; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 75349113494     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.08.014     Document Type: Article

References (38)

1. Chizzolini C. T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis. Curr Opin Rheumatol 20 (2008) 707-712
2. Hasegawa M., Fujimoto M., Takehara K., and Sato S. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 39 (2005) 1-7
3. Yoshizaki A., Iwata Y., Komura K., Ogawa F., Hara T., Muroi E., et al. CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol 172 (2008) 1650-1663
4. McHugh N.J., Whyte J., Artlett C., Briggs D.C., Stephens C.O., Olsen N.J., et al. Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study. Clin Exp Immunol 96 (1994) 267-274
5. Douvas A.S., Achten M., and Tan E.M. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem 254 (1979) 10514-10522
6. Okano Y., Steen V.D., and Medsger Jr. T.A. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 119 (1993) 1005-1013
7. Meyer O.C., Fertig N., Lucas M., Somogyi N., and Medsger Jr. T.A. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 34 (2007) 104-109
8. Reveille J.D., Fischbach M., McNearney T., Friedman A.W., Aguilar M.B., Lisse J., et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 30 (2001) 332-346
9. Gourh P., Tan F.K., Assassi S., Ahn C.W., McNearney T.A., Fischbach M., et al. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis. Arthritis Rheum 54 (2006) 3945-3953
10. Alkassab F., Gourh P., Tan F.K., McNearney T., Fischbach M., Ahn C., et al. An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) 46 (2007) 1248-1251
11. Agarwal S.K., Tan F.K., and Arnett F.C. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 34 (2008) 17-40
12. Wu S.P., Leng L., Feng Z., Liu N., Zhao H., McDonald C., et al. Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma. Arthritis Rheum 54 (2006) 3661-3669
13. Tan F.K., Stivers D.N., Arnett F.C., Chakraborty R., Howard R., and Reveille J.D. HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens 53 (1999) 74-80
14. Tan F.K., Stivers D.N., Foster M.W., Chakraborty R., Howard R.F., Milewicz D.M., et al. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum 41 (1998) 1729-1737
15. Rueda B., Broen J., Simeon C., Hesselstrand R., Diaz B., Suarez H., et al. The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Hum Mol Genet 18 (2009) 2071-2077
16. Hom G., Graham R.R., Modrek B., Taylor K.E., Ortmann W., Garnier S., et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358 (2008) 900-909
17. Harley J.B., arcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 (2008) 204-210
18. Ito I., Kawasaki A., Ito S., Hayashi T., Goto D., Matsumoto I., et al. Replication of the association between the C8orf13-BLK region and systemic lupus erythematosus in a Japanese population. Arthritis Rheum 60 (2009) 553-558
19. Dymecki S.M., Zwollo P., Zeller K., Kuhajda F.P., and Desiderio S.V. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. J Biol Chem 267 (1992) 4815-4823
20. Dymecki S.M., Niederhuber J.E., and Desiderio S.V. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science 247 (1990) 332-336
21. Drebin J.A., Hartzell S.W., Griffin C., Campbell M.J., and Niederhuber J.E. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk). Oncogene 10 (1995) 477-486
22. Islam K.B., Rabbani H., Larsson C., Sanders R., and Smith C.I. Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk. J Immunol 154 (1995) 1265-1272
23. Saijo K., Schmedt C., Su I.H., Karasuyama H., Lowell C.A., Reth M., et al. Essential role of Src-family protein tyrosine kinases in NF-kappaB activation during B cell development. Nat Immunol 4 (2003) 274-279
24. Tretter T., Ross A.E., Dordai D.I., and Desiderio S. Mimicry of pre-B cell receptor signaling by activation of the tyrosine kinase Blk. J Exp Med 198 (2003) 1863-1873
25. Arnett F.C., Reveille J.D., Goldstein R., Pollard K.M., Leaird K., Smith E.A., et al. Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 39 (1996) 1151-1160
26. Anonymous. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic criteria Committee. Arthritis Rheum 23 (1980) 581-590
27. Hummers L.K., Hall A., Wigley F.M., and Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol 36 (2009) 576-582
28. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger Jr. T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15 (1988) 202-205
29. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 357 (2007) 977-986
30. Arnett F.C. Is scleroderma an autoantibody mediated disease?. Curr Opin Rheumatol 18 (2006) 579-581
31. Tan F.K., Zhou X., Mayes M.D., Gourh P., Guo X., Marcum C., et al. Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) 45 (2006) 694-702
32. York M.R., Nagai T., Mangini A.J., Lemaire R., van Seventer J.M., and Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 56 (2007) 1010-1020
33. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100 (2003) 2610-2615
34. Graham R.R., Kyogoku C., Sigurdsson S., Vlasova I.A., Davies L.R., Baechler E.C., et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104 (2007) 6758-6763
35. Peng S.L. Altered T and B lymphocyte signaling pathways in lupus. Autoimmun Rev 8 (2009) 179-183
36. Cancro M.P., D'Cruz D.P., and Khamashta M.A. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest 119 (2009) 1066-1073
37. Yao X.R., and Scott D.W. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc Natl Acad Sci U S A 90 (1993) 7946-7950
38. Zwollo P., Rao S., Wallin J.J., Gackstetter E.R., and Koshland M.E. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation. J Biol Chem 273 (1998) 18647-18655